Our President and CEO, Mr. Hideaki Sato will give a presentation at TIDES Asia Oligonucleotide & Peptide Therapeutics 2025 2025/02/17 Event Read
Our President and CEO, Mr. Sato, will participate in “Go Global! English Pitch Competition 2024” as a finalist. 2025/02/17 Event Read
Our President & CEO, Mr. Hideaki Sato, will be a speaker at the “Healthcare Conference Taipei 2025”. 2025/02/17 Event Read
Notice of Conclusion of License Agreement with Summit Pharmaceuticals International Corporation for the Manufacture and Sale of Artificial Modified Nucleic Acid Amidite 2024/12/17 Notice Read
The “Hello Tomorrow JAPAN Deep Tech Summit 2024” has selected our President and CEO, Mr. Hideaki Sato, as a finalist in [Japan Challenge 2024] 2024/12/05 Event Read
Result of the Ex-post evaluation of the Spinal Cord Injury (SCI) Program of Cyclic Innovation for Clinical Empowerment (CiCLE) supported by Japan Agency for Medical Research and Development (AMED) 2024/11/28 Notice Read